Vestibular Balance Therapy Intervention for Children (VBT-C)

April 3, 2024 updated by: Jennifer Braswell Christy, University of Alabama at Birmingham

Feasibility of a Home-Based Vestibular Balance Therapy Intervention for Children With Vestibular Hypofunction

The goal of this within groups clinical trial is to determine the feasibility of a home-based vestibular balance therapy program for children with vestibular hypofunction. The main questions to be answered are: 1) what is the intervention's feasibility and 2) what is the intervention's preliminary impact on function? Participants will receive a comprehensive battery of vestibular function and balance tests, then an 8-week home-based intervention to be done 5 times/week with weekly checks from the physical therapist. Data will be used to design a larger clinical trial with a comparison group.

Study Overview

Detailed Description

Approximately 60-75% of children with severe/profound sensorineural hearing loss (SNHL) also have vestibular hypofunction (VH), resulting in delayed gross motor development, poor postural control, and gaze instability. Although clinical practice guidelines provide recommendations for adults with VH, no statements exist for children due to a paucity of high- level studies. The long-term objective of this proposal is to assess feasibility of a home-based vestibular balance therapy (VBT) program for children so that a larger well-powered controlled study can be designed. The specific aims are to assess the intervention's feasibility (Aim 1), estimate its preliminary impact on functional outcomes (Aim 2), and assess participant engagement (secondary Aim). To accomplish this, we will use a prospective single arm feasibility design. We will enroll 15 children with SNHL, aged 6-12 years; 12 with confirmed VH for the VBT, and 3 with normal vestibular function to test the sham intervention. All children will be tested on the functional outcomes: computerized dynamic visual acuity, modified functional gait assessment, and sensory organization test at baseline, 4, and 8 weeks. A physical therapist (PT) will train children/caregivers in the 8-week structured VBT home program consisting of 4 categories of exercises (Times 1 viewing, gaze shifting, static and dynamic balance) done 5 times/week, 5 minutes/exercise. The PT will meet weekly with the child/caregiver in person to systematically progress the exercises. The children in the sham intervention (10 minutes of reading, 10 minutes of play) will also receive weekly meetings with the PT to control for attention bias. To assess Aim 1 (Feasibility) metrics will include process (e.g., recruitment rates), resources (e.g., communication needs), management (e.g., data collection/entry), experience (e.g., barriers). To assess Aim 2 (impact) we will analyze within group changes and effect sizes to design the larger study.

Study Type

Interventional

Enrollment (Estimated)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Michael A. Matthews
  • Phone Number: 205-934-5266
  • Email: osp@uab.edu

Study Contact Backup

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35294
        • Recruiting
        • UAB
        • Contact:
        • Contact:
        • Principal Investigator:
          • Jennifer B Christy, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 12 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • confirmed diagnosis of severe to profound SNHL
  • age 6-12 years
  • caregiver/child verbal willingness to commit to the home vestibular balance therapy or sham intervention
  • vision screening/testing within 1 year or willingness to get a vision test.

Exclusion Criteria:

  • neurologic condition other than SNHL
  • inability to read at a kindergarten level or identify pictures
  • currently receiving vestibular therapy
  • uncorrected vision problems unrelated to a vestibular deficit

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: VBP Intervention Group
Children coded as abnormal on functional tests (FT) (n=12) will participate in an 8-week 5X/week home-based VBT program. At the initial visit (T0), the PI will instruct the participants (caregiver and child) in the program and provide all materials. The exercises will be led by the caregiver, with weekly in person checks by the PI to progress and provide coaching. The child/caregiver will complete a daily log to report activities and level of enjoyment. VBT will be done 5 days/week and will include 4 key categories of exercises, each lasting 5 minutes (20 minutes total of exercise per day). The 4 categories, explained below, include: 1) Times 1 (X1) Viewing, 2) Gaze Shifting, 3) Static Balance, 4) Dynamic Balance. The proposed VBT home program will include 10 minutes of gaze stabilization exercises, and 10 minutes of balance training.
see intervention arm description
Other Names:
  • Vestibular Rehabilitation
Sham Comparator: Sham Intervention

Sham Intervention (not to be compared to intervention - for feasibility only):

Aim 1 is to establish the feasibility of a control intervention to be used in future studies. Therefore, 3 participants who score above the set criterion for the Functional Tests (FT) (i.e., they do not need VBT) will participate in an 8-week sham intervention. At T0, the PI will instruct the participants to do the sham intervention, led by the caregiver with weekly checks to control for attention bias. The sham intervention will be done for 20 minutes per day and will consist of 10 minutes of focused reading a book of the child's choice and 10 minutes of active play. The child and caregiver will complete a daily activity log documenting the activity and level of enjoyment.

see sham intervention arm description

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Computerized Dynamic Visual Acuity at 4 and 8 weeks
Time Frame: Baseline (pre), 4 weeks (mid), 8 weeks (post)
Difference in visual acuity with the head stationary versus moving
Baseline (pre), 4 weeks (mid), 8 weeks (post)
Change in Functional Gait Assessment at 4 and 8 weeks
Time Frame: Baseline (pre), 4 weeks (mid), 8 weeks (post)
A standardized test of dynamic balance
Baseline (pre), 4 weeks (mid), 8 weeks (post)
Change in Sensory Organization Test at 4 and 8 weeks
Time Frame: Baseline (pre), 4 weeks (mid), 8 weeks (post)
A standardized test of static postural control
Baseline (pre), 4 weeks (mid), 8 weeks (post)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Process Feasibility (Recruitment Rates)
Time Frame: through study completion at 2 years
% of individuals who follow through with enrollment procedures
through study completion at 2 years
Process Feasibility (Refusal Rate Frequency)
Time Frame: through study completion at 2 years
Frequency of refusal to participate in the study
through study completion at 2 years
Process Feasibility (Attrition Rates)
Time Frame: through study period at 2 years
% of attrition
through study period at 2 years
Process Feasibility (Retention Rates)
Time Frame: through study period at 2 years
% of retention
through study period at 2 years
Process Feasibility (Completion Rates)
Time Frame: through study period at 2 years
% of participants who complete 80% of intervention sessions
through study period at 2 years
Management Feasibility (training)
Time Frame: through year 1
time in minutes to train data collectors
through year 1
Management Feasibility (data entry)
Time Frame: through year 1
time in minutes for data entry
through year 1
Participant Experience Feasibility (Strategies)
Time Frame: through study period at 2 years
participant strategies that helped them with participation in the study (interview)
through study period at 2 years
Participant Experience Feasibility (Enjoyment)
Time Frame: through the study period at 2 years
Enjoyment level for each participant (ordinal scale of 0=no enjoyment to 10=extreme enjoyment)
through the study period at 2 years
Participant Experience Feasibility (Testing Difficulty)
Time Frame: baseline only - initial testing session
Participants will rate the level of difficulty of the initial testing session (0=not difficult to 10=extreme difficulty)
baseline only - initial testing session
Participant Experience Feasibility (Intervention Difficulty)
Time Frame: once, at each participant's final testing session (8 weeks)
Participants will rate the level of difficulty of the overall intervention (0=not difficult to 10=extreme difficulty)
once, at each participant's final testing session (8 weeks)
Resource Feasibility (frequency)
Time Frame: through study period at 2 years
Frequency of communication with participants
through study period at 2 years
Resource Feasibility (time)
Time Frame: through study period at 2 years
Total time in minutes to communicate with participants
through study period at 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jennifer B Christy, PhD, University of Alabama at Birmingham

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 28, 2023

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

January 25, 2023

First Submitted That Met QC Criteria

February 22, 2023

First Posted (Actual)

February 23, 2023

Study Record Updates

Last Update Posted (Actual)

April 5, 2024

Last Update Submitted That Met QC Criteria

April 3, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The PI plans to share the data via typical methods such as manuscripts and professional conferences.

IPD Sharing Time Frame

The data will be shared after study completion and following analysis. The PI may choose to share preliminary data at a conference.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vestibulocochlear Nerve Diseases

Clinical Trials on Vestibular Balance Therapy

3
Subscribe